Multivariable logistic regression showed the odds of a term delivery occurring at 39 weeks or more was 38% higher after guideline enforcement when compared with before (adjusted odds ratio [OR] 1.38, 95% confidence interval [CI] 1.30–1.47) adjusted for patient age, type, insurance, race, marital status, obesity, gestational weight gain, parity, a diagnosis of prepregnancy diabetes, gestational diabetes, chronic hypertension, and hypertension during pregnancy. Tests of interaction identified significant differences by parity, insurance type, and race and ethnicity.
Stratified analysis, adjusting for the same factors, showed that the odds of a term delivery increased more for multiparous women (adjusted OR 1.47, 95% CI 1.37–1.58) than for nulliparous women (adjusted OR 1.22, 95% CI 1.11–1.35). There was also a greater magnitude of change for patients with private insurance (adjusted OR 1.50, 95% CI 1.40–1.62) than for women who were uninsured or receiving Medicaid (adjusted OR 1.18, 95% CI 1.07–1.30). The stratified analysis by race showed the differences after implementation were greatest for white women (adjusted OR 1.56, 95% CI 1.44–1.68) than for African American women (adjusted OR 1.17, 95% CI 1.04–1.32) and no different for women reporting Hispanic race or ethnicity (adjusted OR 1.0; 95% CI 0.83–1.19).
Table 2 describes overall neonatal characteristics before and after. Among live births, the median 1- and 5-minute Apgar scores were significantly lower after the intervention, when tested using the Wilcoxon rank sum test (P<.001 for 1 minute; P=.023 for 5 minute). The percentage of neonates with 5-minute Apgar scores of 3 or less did not change (P=.39).
The overall rate of admission to the NICU was significantly different between the two periods; before the intervention, there were 1,116 admissions (9.29% of term live births), whereas after, there were 1,027 (8.55% of term live births) and this difference was significant (P=.044). Multivariable logistic regression revealed a reduced odds of a NICU admission (adjusted OR 0.92, 95% CI 0.84–1.01) after the intervention. There were significant interaction effects with race. The results of the multivariable logistic regression stratified by maternal race are shown in Table 3, indicating the change was significant only for those neonates born to women reporting white race.
No statistically significant difference in the mean birth weight between the periods was identified. There was an increase in the fraction of neonates with a birth weight 4,000 g or more and 4,500 g or more, but neither were statistically significant (P=.22 and P=.65, respectively). The multivariable logistic regression, accounting for changes in the characteristics of the cohort, gave an increased adjusted OR for a neonate 4,000 g or more (adjusted OR 1.11, 95% CI 1.01–1.22) after the intervention when compared with before. Analysis stratified by maternal race is shown in Table 3. The increase in macrosomia was statistically significant for neonates of women reporting white race; the point estimate for neonates of African American women was greater than 1 but failed to reach significance, possibly as a result of the smaller sample size. Neonates born to Hispanic women had reduced odds of macrosomia.
Table 4 provides a detailed accounting of the stillbirths identified; seven were identified before and 17 after. Two of the stillbirths after the intervention had congenital anomalies and were eliminated from the statistical analysis. The overall rate of stillbirth of nonanomalous fetuses differed between the periods with an overall increased risk of stillbirth after the intervention (relative risk 2.14, 95% CI 0.87–5.26, P=.06); this overall increase was not statistically significant. However, stratification by gestational age group of the stillbirth revealed the increased risk in the after group was limited to stillbirths before 39 weeks, which increased from 2.5 to 9.1 per 10,000 term pregnancies (relative risk 3.67, 95% CI 1.02–13.15, P=.032), whereas there was no change in risk of stillbirth at 39 weeks or more (relative risk 0.91, 95% CI 0.23–3.64, P=.896).
The authors carefully reviewed the medical records of each stillbirth to identify cause of death and the presence of a maternal risk factor; these findings are shown in Table 5. No definitive cause-of-death pattern emerged. We reviewed the characteristics of the women who delivered stillborn fetuses during each period to identify maternal factors that might be indications for delivery. Of the women who delivered before the intervention, four women were white, two Hispanic, and one Asian; one woman was older than 35 years. Of the 17 women who delivered stillborn fetuses after the intervention, nine (53%) were white, five African American (29%), and two Hispanic (12%); nine women (53%) had risk factors related to advanced age or medical diagnosis. Findings related to results of antenatal testing completed before hospital admission for delivery were not available.
Using data derived from perinatal obstetric records, we found implementation of delivery guidelines at a large community-based hospital system led to a significant decrease in the fraction of term singleton births delivered at 37 or 38 weeks of gestation. Important contributors to this change were a decline in the fraction of repeat cesarean deliveries and elective inductions performed before 39 weeks. The shift was greatest for patients who were privately insured, multiparous, or white.
The change in obstetric practice was associated with differences in the three neonatal outcomes we examined for the population. We found a small decrease in the rate of NICU admissions for neonates born at term. This difference was of marginal statistical significance after adjusting for changes in the characteristics of the women between the two time periods. The magnitude of the effect was greatest for neonates born to white women. This is consistent with the finding that this was the group of women who showed the greatest reduction in the fraction of neonates born at 37 or 38 weeks after the guidelines were introduced. Rates of admission to the NICU at this institution were high for this gestational age group, potentially because there is no intermediate care nursery, but there was no indication that there were changes in the policy that occurred over the time period studied.
We found evidence to suggest potential adverse outcomes associated with the reductions in 37- and 38-week elective deliveries. There was a small increase in the percentage of neonates whose birth weight was 4,000 g or more. This could be an expected results of the extended duration of pregnancy and the limitations of clinical assessment of fetal macrosomia.18 We were unable to estimate the clinical consequences of this finding using the currently available data. Given the well-established morbidities associated with macrosomia, including shoulder dystocia, this small increase is of potential importance on a population level.
Also of concern is the increase in the number of stillbirths at term of sufficient magnitude to be detected in this analysis. By including only singleton pregnancies, we eliminated the possibility that the change was the result of a decrease in multiple gestation pregnancies, a group at higher risk for stillbirth. The excess in stillbirths occurred at 37 or 38 weeks, raising the concern that earlier delivery might have produced different outcomes. Although the numbers are too small to draw conclusions, they call for the monitoring of trends in stillbirth rates, especially among women with the common risk factors such as age 35 years and older and any type of diabetes or hypertension.
The successful change in obstetric practice observed in this large community hospital is consistent with the experiences of other institutions and regions that have modified obstetric practice through the use of guidelines and monitoring.11 – 15 The differential effect by race is an interesting and new finding, which might reflect a reversal of the historical trend of greater obstetric intervention at term for white, insured women in this community.16
Prior studies have not reported adverse effects on neonatal outcomes associated with similar changes in obstetric practice. Two earlier studies also observed a decline in NICU admission, and neither detected an increase in stillbirth after implementation of guidelines.11,14 An elevation in the risk of macrosomia also has not been observed, but careful accounting for changes in the maternal characteristics associated with that outcome was not conducted.14 The differences in these findings may be the result of differences in the characteristics of the populations studied or potentially related to our ability to adjust for confounding factors.
There are important limitations that should be considered when interpreting the results of this study. Errors in the estimates of gestational age could have led to misclassification of stillbirths, although our chart review suggests this was unlikely. It is also possible that other factors influenced obstetric care, perinatal outcomes, or both over the time periods studied that are independent of the guidelines and account for the changes in obstetric or neonatal outcomes we have observed. For example, the decision to admit a neonate to the NICU could be affected by changes in neonatal care and might not reflect differences in clinically important outcomes of the neonate. We attempted to account for these possibilities by limiting the time period studied and through a careful adjustment for changing characteristics of the populations. Moreover, our findings represent the experience of a single center and may not accurately predict experience at centers where obstetric practices differ or where there are differences in the patient population. Importantly, although the findings are statistically significant, their association with the intervention may not be causal and could be simply the result of chance.
We believe there are several strengths to this study design. The before and after approach is often used in the evaluation of interventions such as this that cannot be applied randomly to a population. The use of clinical data provided more reliable outcome measures than those available from administrative or vital statistics data. Because these data are derived from the institutional data warehouse, they could be validated by review of the individual patient medical record. Of further importance, the clinical data also included pertinent covariates allowing adjustment for changes in the characteristics of the obstetric population. This helps to reduce the largest threat to the validity of the study findings that might result from differences in the cohorts between the two periods. The large size of the population provided sufficient power to detect changes in low-frequency events such as stillbirth.
The findings of this and other studies demonstrate that large institutions are able to enforce evidence-based guidelines and affect the clinical practice of community providers. These changes have occurred in a setting of increased attention by the National Committee for Quality Assurance and other organizations responsible for assessing quality of care and may have been an important motivator for the institution. The change in practice was associated with a lower rate of admission to the NICU, which remained of marginal significance after adjusting for changes in the characteristics of the cohort. The finding that changes in obstetric outcomes varied by race, and other maternal factors, suggests these characteristics need to be considered carefully when evaluating the effectiveness of these recommendations when applied to populations.
The detection of an increase in the rate of macrosomia and stillbirth is of concern. Macrosomia is well established to be associated with greater risk of shoulder dystocia, neonatal hypoglycemia, and hyperbilirubinemia.18 With national trends showing increased rates of diabetes and other causative factors, this would be an important outcome to monitor in different geographic and ethnic populations. The higher rate of stillbirth before 39 weeks is of course what we are all concerned about when we delay delivery. Our current data suggest that this may have involved women with medical risk factors and point to a need for surveillance of stillbirth rates, especially in the growing population of at-risk women.
We are in the midst of a national effort to eliminate elective delivery during the early-term period to optimize neonatal outcomes.20,21 This effort is guided by consistent findings from observational studies conducted in a variety of settings. However, none of these data are derived from randomized controlled trials. It is therefore critically important that the clinical outcomes resulting from the broad application of these practice guidelines be monitored carefully in large population-based settings to ensure there are no unintended adverse consequences. The study of outcomes after implementation of guidelines at institutions across the country is needed to generate sufficient power to detect changes in outcomes and to generate the evidence needed to tailor clinical care. Only then can the balance of the risks and benefits associated with the implementation of guidelines limiting elective delivery before 39 weeks be debated.
1. Davidoff MJ, Dias T, Damus K, Russell R, Bettegowda VR, Dolan S, et al.. Changes in the gestational age distribution among US singleton births: impact on rates of late preterm birth, 1992 to 2002. Semin Perinatol 2006;30:8–15.
2. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, et al.. Births: Final data for 2006. National vital statistics reports. Hyattsville (MD): National Center for Health Statistics; 2009.
3. Zhang J, Troendle J, Reddy UM, Laughon SK, Branch DW, Burkman R, et al.. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol 2010;203:326.e1–10.
4. Clark SL, Miller DD, Belfort MA, Dildy GA, Frye DK, Meyers JA. Neonatal and maternal outcomes associated with elective term delivery. Am J Obstet Gynecol 2009;200:156.e1–4.
5. Tita AT, Landon MB, Spong CY, Lai Y, Leveno KJ, Varner MW, et al.. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009;360:111–20.
6. Wilmink FA, Hukkelhoven CW, Lunshof S, Mol BW, van der Post JA, Papatsonis DN. Neonatal outcome following elective cesarean section beyond 37 weeks of gestation: a 7-year retrospective analysis of a national registry. Am J Obstet Gynecol 2010;202:250.e1–8.
7. Zhang X, Kramer MS. Variations in mortality and morbidity by gestational age among infants born at term. J Pediatr 2009;154:358–62, 362.e1.
8. Bailit JL, Gregory KD, Reddy UM, Gonzalez-Quintero VH, Hibbard JU, Ramirez MM, et al.. Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol 2010;202:245.e1–12.
9. Induction of labor. ACOG Practice Bulletin No. 107. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;114:386–97.
11. Clark SL, Frye DR, Meyers JA, Belfort MA, Dildy GA, Kofford S, et al.. Reduction in elective delivery at <39 weeks of gestation: comparative effectiveness of 3 approaches to change and the impact on neonatal intensive care admission and stillbirth. Am J Obstet Gynecol 2010;203:449.41–6.
12. Donovan EF, Lannon C, Bailit J, Rose B, Iams JD, Byczkowski T. A statewide initiative to reduce inappropriate scheduled births at 36(0/7)–38(6/7) weeks' gestation. Am J Obstet Gynecol 2010;202:243.e1–8.
13. Fisch JM, English D, Pedaline S, Brooks K, Simhan HN. Labor induction process improvement: a patient quality-of-care initiative. Obstet Gynecol 2009;113:797–803.
14. Oshiro BT, Henry E, Wilson J, Branch DW, Varner MW. Decreasing elective deliveries before 39 weeks of gestation in an integrated health care system. Obstet Gynecol 2009;113:804–11.
15. Reisner DP, Wallin TK, Zingheim RW, Luthy DA. Reduction of elective inductions in a large community hospital. Am J Obstet Gynecol 2009;200:674.e1–7.
16. Ehrenthal DB, Jiang X, Strobino DM. Labor induction and the risk of a cesarean delivery among nulliparous women at term. Obstet Gynecol 2010;116:35–42.
17. Ehrenthal DB, Jurkovitz C, Hoffman M, Jiang X, Weintraub WS. Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertension. J Womens Health (Larchmt) 2011;20:67–72.
18. Chatfield J. ACOG issues guidelines on fetal macrosomia. American College of Obstetricians and Gynecologists. Am Fam Physician 2001;64:169–70.
19. Joseph KS. The fetuses-at-risk approach: clarification of semantic and conceptual misapprehension. BMC Pregnancy Childbirth 2008;8:11.
20. Ashton DM. Elective delivery at less than 39 weeks. Curr Opin Obstet Gynecol 2010;22:506–10.
© 2011 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
21. Fleischman AR, Oinuma M, Clark SL. Rethinking the definition of ‘term pregnancy.’ Obstet Gynecol 2010;116:136–9.